Experion Holdings Ltd (TSXV: EXP), through its wholly-owned subsidiary, Experion Biotechnologies has been granted an amendment for its Health Canada license to increase capacity at the company’s facility located in Mission, British Columbia.
Effective immediately, the licencing amendment will allow Experion to increase cultivation capacities by 20%, with which the company plans to grow cannabis flower sometime in April. Also part of the Health Canada licencing amendment, Experion now has approval for several processing rooms, which will increase operational efficiency by running various processing activities at once. Given the expansion in processing rooms, the company will also be able to focus some of its effort towards diversifying its product availability.
Amid the COVID-19 outbreak, cannabis production has been deemed as an essential service, and thus Experion will use this licensing amendment to process hundreds of kilograms per month of cannabis, and launch pre-rolls in addition to other value-added cannabis products.
Experion Holdings Ltd is headquartered in Mission, BC, and is a licenced cannabis cultivator and processor. The company is currently trading at $0.06 on the TSX-Venture.
Information for this briefing was found via Sedar and Experion Holdings Ltd. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.
